Dysregulation of the renin-angiotensin system in septic shock: Mechanistic insights and application of angiotensin II in clinical management
- PMID: 34597810
- DOI: 10.1016/j.phrs.2021.105916
Dysregulation of the renin-angiotensin system in septic shock: Mechanistic insights and application of angiotensin II in clinical management
Abstract
Synergistic physiologic mechanisms involving the renin-angiotensin system (RAS), the sympathetic nervous system, and the arginine-vasopressin system play an integral role in blood pressure homeostasis. A subset of patients with sepsis experience septic shock with attendant circulatory, cellular, and metabolic abnormalities. Septic shock is associated with increased mortality because of an inadequacy to maintain mean arterial blood pressure (MAP) despite volume resuscitation and the use of vasopressors. Vasodilatory shock raises the dose of vasopressors required to maintain a MAP of > 65 mm Hg. The diminished response to endogenous angiotensin II in sepsis-induced vasoplegia may be related to the aberrant RAS activation that stimulates a proinflammatory beneficial antibacterial response, increasing the secretion of proinflammatory cytokines that downregulate AT-1 receptors expression. Moreover, excessive systemic upregulation of nitric oxide synthase, stimulation of prostaglandin synthesis, and activation of ATP-sensitive potassium channels followed by reduced vascular entry of calcium ions are putative mechanisms in the reduced responsiveness to vasopressors. However, intravenous angiotensin II in catecholamine-resistant septic shock patients showed substantial evidence of raising the MAP to target hemodynamic levels, thus allowing time to treat underlying conditions. Nevertheless, evidence of catecholamine-sparing effect by adding angiotensin II, aimed at increasing the therapeutic index of vasopressor therapy, does not show an attenuation of end-organ damage. The use of angiotensin II in septic shock has not been evaluated in patients who are not catecholamine resistant. This, in conjunction with an evolving definition of catecholamine resistance, provides an opportunity for further evaluation of exogenous angiotensin II in septic shock.
Keywords: Angiotensin II; Catecholamine resistant shock; Hypotension; Renin-angiotensin system; Septic shock; Vasodilatory shock.
Published by Elsevier Ltd.
Similar articles
-
Angiotensin II in septic shock.Am J Emerg Med. 2019 Jun;37(6):1169-1174. doi: 10.1016/j.ajem.2019.03.026. Epub 2019 Mar 19. Am J Emerg Med. 2019. PMID: 30935784 Review.
-
Angiotensin II in Refractory Septic Shock.Shock. 2017 May;47(5):560-566. doi: 10.1097/SHK.0000000000000807. Shock. 2017. PMID: 27879559 Review.
-
FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock.Am J Cardiovasc Drugs. 2019 Feb;19(1):11-20. doi: 10.1007/s40256-018-0297-9. Am J Cardiovasc Drugs. 2019. PMID: 30144016 Clinical Trial.
-
The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock.Trials. 2024 Mar 12;25(1):182. doi: 10.1186/s13063-024-07995-0. Trials. 2024. PMID: 38475822 Free PMC article.
-
THE ROLE OF ANGIOTENSIN -2 IN THE PATHOGENESIS OF SEPTIC SHOCK DURING MULTIORGAN DYSFUNCTION SYNDROME (REVIEW).Georgian Med News. 2022 Feb;(323):157-161. Georgian Med News. 2022. PMID: 35271489
Cited by
-
Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review.World J Crit Care Med. 2023 Sep 9;12(4):204-216. doi: 10.5492/wjccm.v12.i4.204. eCollection 2023 Sep 9. World J Crit Care Med. 2023. PMID: 37745258 Free PMC article. Review.
-
A perspective on small molecules targeting the renin-angiotensin-aldosterone system and their utility in cardiovascular diseases: exploring the structural insights for rational drug discovery and development.RSC Med Chem. 2025 Jan 21. doi: 10.1039/d4md00720d. Online ahead of print. RSC Med Chem. 2025. PMID: 39925732 Free PMC article. Review.
-
Pharmacologic and endotoxic reprogramming of renal vasodilatory, inflammatory, and apoptotic blemishes in weaning preeclamptic rats.Sci Rep. 2025 Mar 8;15(1):8137. doi: 10.1038/s41598-025-87586-4. Sci Rep. 2025. PMID: 40057533 Free PMC article.
-
Luteolin improves vasoconstriction function and survival of septic mice via AMPK/NF-κB pathway.Heliyon. 2023 Jan 31;9(2):e13330. doi: 10.1016/j.heliyon.2023.e13330. eCollection 2023 Feb. Heliyon. 2023. PMID: 36816271 Free PMC article.
-
Pericytes protect rats and mice from sepsis-induced injuries by maintaining vascular reactivity and barrier function: implication of miRNAs and microvesicles.Mil Med Res. 2023 Mar 13;10(1):13. doi: 10.1186/s40779-023-00442-2. Mil Med Res. 2023. PMID: 36907884 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials